ATIC and chronic myelogenous leukemia, BCR-ABL1 positive: We conclude that the never-before-screened genetic variants of the genes ATIC (rs2372536) and ARID5B (rs10821936) play a role in therapeutic failure with imatinib, the gold standard treatment for CML.